Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Beckman Coulter Beckman Coulter Stem-Trol Control Cells - Ready-to-Use CD34/CD45 Positive Control (IM3632US, 10 Tests)

Catalog No. NC3446128
Encompass

Beckman Coulter Stem-Trol Control Cells (IM3632US) are a preserved, ready-to-use cell suspension that provides an antibody-to-antigen positive control for CD34 and CD45 staining in flow cytometry and serves as an internal control for CD34+ absolute counting procedures.

  • Ready-to-use preserved cell suspension.
  • Designed to mimic human hematopoietic progenitor cells expressing CD34 and CD45.
  • Provides an antibody-to-antigen positive control for CD34 and CD45 staining.
  • Precisely calibrated concentration for absolute count verification.
  • Labeled for in vitro diagnostic use (IVD).
  • Packaged for approximately 10 tests per kit.

Catalog No. NC3446128 Supplier Beckman Coulter Supplier No. IM3632US
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Beckman Coulter Stem-Trol Control Cells (IM3632US) are a preserved, ready-to-use cell suspension that provides an antibody-to-antigen positive control for CD34 and CD45 staining in flow cytometry and serves as an internal control for CD34+ absolute counting procedures.

  • Ready-to-use preserved cell suspension.
  • Designed to mimic human hematopoietic progenitor cells expressing CD34 and CD45.
  • Provides an antibody-to-antigen positive control for CD34 and CD45 staining.
  • Precisely calibrated concentration for absolute count verification.
  • Labeled for in vitro diagnostic use (IVD).
  • Packaged for approximately 10 tests per kit.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.